CoChat

RETRACTED: Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats

Salem, Ahmed M., Ahmed, Hanaa H., Atta, Hazem M., Ghazy, Mohamed A., Aglan, Hadeer A. · 2014 · Cell Biology International
Cited by 56

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease (AD) has been called the disease of the century with significant clinical and socioeconomic impacts. Pharmacological treatment has limited efficacy and only provides symptomatic relief without long‐term cure. Accordingly, there is an urgent need to develop novel and effective medications for AD. Stem cell‐based therapy is a promising approach to handling neurodegenerative diseases. Therefore, the current study aimed to explore the possible therapeutic role of single intravenous injection of bone marrow derived mesenchymal stem cells (BM‐MSCs) after 4 months in management of AD in the experimental model. The work also extended to compare the therapeutic potential of BM‐MSCs with 2 conventional therapies of AD; rivastigmine and cerebrolysin administered daily. BM‐MSCs were able to home at the injured brains and produced significant increases in the number of positive cells for choline acetyltransferase (ChAT) and survivin expression, as well as selective AD indicator‐1 (seladin‐1) and nestin gene expression. Histopathological examination indicated that BM‐MSCs could remove beta‐amyloid plaques from hippocampus. Significant improvement in these biomarkers was similar to or better sometimes than the reference drugs, clearly showing the potential therapeutic role of BM‐MSCs against AD through their anti‐apoptotic, neurogenic and immunomodulatory properties.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cbin.10331This paper is marked retracted.

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 56

Metadata

Authors
Salem, A. M., Ahmed, H. H., Atta, H. M., Ghazy, M. A., & Aglan, H. A.
Venue
Cell Biology International
Publisher
Wiley
Published
2014-07-17
Volume
38
Issue
12
Pages
1367-1383
ISSN
  • 1065-6995 (ISSN-L)
  • 1095-8355
OpenAlex
W2106585367
Cited by
56
References
7
FWCI
4.50
Type
journal article
Language
en
Status
Retracted
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.